DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway

[1]  H. Koga,et al.  Upregulation of T‐cell factor‐4 isoform‐responsive target genes in hepatocellular carcinoma , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[2]  Bin Wang,et al.  Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44+ gastric cancer cells via attenuating Wnt signaling , 2013, Journal of Gastroenterology.

[3]  N. Munshi,et al.  In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma. , 2013, Bone.

[4]  Zhen Liu,et al.  Dickkopf-1 (DKK1) promotes invasion and metastasis of hepatocellular carcinoma. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  Zhao-You Tang,et al.  High expression of Dickkopf‐related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery , 2013, Cancer.

[6]  C. Niehrs,et al.  Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. , 2013, Cell stem cell.

[7]  J. Luk,et al.  Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma , 2012, Oncogene.

[8]  Hongyang Wang,et al.  Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. , 2012, The Lancet. Oncology.

[9]  Baocun Sun,et al.  Dickkopf‐1 inhibits epithelial‐mesenchymal transition of colon cancer cells and contributes to colon cancer suppression , 2012, Cancer science.

[10]  Ya-hong Zhang,et al.  3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway , 2012, Apoptosis.

[11]  Youhua Liu,et al.  Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[12]  Hongyue Dai,et al.  Clinicopathological and prognostic significance of serum and tissue Dickkopf‐1 levels in human hepatocellular carcinoma , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[13]  Jing Ping Zhang,et al.  MicroRNA‐29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression , 2011, Hepatology.

[14]  S. Qiu,et al.  Tumor stroma reaction‐related gene signature predicts clinical outcome in human hepatocellular carcinoma , 2011, Cancer science.

[15]  C. Ishikawa,et al.  Human T-cell leukemia virus type 1 tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling. , 2011, Biochimica et biophysica acta.

[16]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[17]  Steven M. Lipkin,et al.  The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling , 2010, Oncotarget.

[18]  K. Kreuzer,et al.  Evidence for non‐functional Dickkopf‐1 (DKK‐1) signaling in chronic lymphocytic leukemia (CLL) , 2010, European journal of haematology.

[19]  J. Yun,et al.  MicroRNA‐195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells , 2009, Hepatology.

[20]  L. Hood,et al.  Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. , 2009, Journal of hepatology.

[21]  I. Ng,et al.  Rho‐kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion , 2009, Hepatology.

[22]  J. Bruix,et al.  Molecular targeted therapies in hepatocellular carcinoma , 2008, Hepatology.

[23]  S. Hirohashi,et al.  A New Formula for Predicting Liver Metastasis in Patients with Colorectal Cancer: Immunohistochemical Analysis of a Large Series of 439 Surgically Resected Cases , 2008, Oncology.

[24]  Hang Zhang,et al.  Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. , 2007, Translational research : the journal of laboratory and clinical medicine.

[25]  S. Monga,et al.  WNT/β‐catenin signaling in liver health and disease , 2007 .

[26]  Y. Miyagi,et al.  Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. , 2007, Cancer research.

[27]  Y. Takeda,et al.  Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. , 2007, Surgery.

[28]  S. Turcotte,et al.  The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types , 2007, British Journal of Cancer.

[29]  A. Muñoz,et al.  The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer , 2005, Oncogene.

[30]  A. Zorn,et al.  Wnt signalling: Antagonistic Dickkopfs , 2001, Current Biology.

[31]  Katsuaki Tanaka,et al.  Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor , 2008, Oncology reports.

[32]  S. Monga,et al.  WNT/beta-catenin signaling in liver health and disease. , 2007, Hepatology.

[33]  U. Schumacher,et al.  Universitätsklinikum Hamburg-Eppendorf , 2006 .